Dose Reduction to the Swallowing Apparatus and the Salivary Glands by De-Intensification of Postoperative Radiotherapy in Patients with Head and Neck Cancer: First (Treatment Planning) Results of the Prospective Multicenter DIREKHT Trial.

de-intensification head neck cancer ipsilateral elective neck irradiation only postoperative radiotherapy salivary glands swallowing apparatus

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
26 Feb 2020
Historique:
received: 15 01 2020
revised: 07 02 2020
accepted: 20 02 2020
entrez: 1 3 2020
pubmed: 1 3 2020
medline: 1 3 2020
Statut: epublish

Résumé

Evaluating radiotherapy treatment plans of the prospective DIREKHT trial (ClinicalTrials.gov, NCT02528955) investigating de-intensification of radiotherapy in patients with head and neck cancer. The first 30 patients from the DIREKHT trial of the leading study centre were included in this analysis. Standard treatment plans and study treatment plans derived from the protocol were calculated for each patient. Sizes of planning target volumes (PTVs) and mean doses to organs at risk were compared using the Student's t-test with paired samples. Mean PTV3 including primary tumor region and ipsilateral elective neck up to a dose of 50 Gy in the study treatment plans was 662 mL (+/- 165 mL standard deviation (SD)) and therefore significantly smaller than those of the standard treatment plans (1166 mL (+/- 266 mL SD). In the medial and inferior constrictor muscles, cricopharyngeal muscle, glottic and supraglottic laryngeal areas, arytenoid cartilages, contralateral major salivary glands highly significant dose reductions ( De-intensification of radiotherapy led to smaller planning target volumes and clinical relevant dose reductions in the swallowing apparatus and in the contralateral salivary glands.

Identifiants

pubmed: 32110958
pii: cancers12030538
doi: 10.3390/cancers12030538
pmc: PMC7139715
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02528955']

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

On behalf of all authors the corresponding author states that there is no conflict of interest.

Références

Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1110-8
pubmed: 18468812
Strahlenther Onkol. 2017 Aug;193(8):656-665
pubmed: 28653120
Clin Otolaryngol. 2006 Jun;31(3):204-11
pubmed: 16759240
Lancet Oncol. 2011 Feb;12(2):127-36
pubmed: 21236730
BMC Cancer. 2016 Oct 6;16(1):770
pubmed: 27716125
Radiat Oncol. 2016 Nov 15;11(1):151
pubmed: 27846899
J Clin Oncol. 2007 Nov 1;25(31):4873-9
pubmed: 17971582
J Clin Oncol. 2010 Jun 1;28(16):2732-8
pubmed: 20421546
Radiother Oncol. 2013 Jun;107(3):288-94
pubmed: 23791365
Cancers (Basel). 2017 Oct 06;9(10):
pubmed: 28984841
Strahlenther Onkol. 2019 Dec 12;:
pubmed: 31832696
N Engl J Med. 2004 May 6;350(19):1945-52
pubmed: 15128894
Gulf J Oncolog. 2012 Jul;(12):17-26
pubmed: 22773212
Int J Radiat Oncol Biol Phys. 1993 Apr 30;26(1):3-11
pubmed: 8482629
Head Neck. 2019 Jun;41(6):1984-1998
pubmed: 30680831
Strahlenther Onkol. 2013 Mar;189(3):216-22
pubmed: 23354440
J Clin Oncol. 2019 Oct 1;37(28):2548-2555
pubmed: 31246526
Strahlenther Onkol. 2019 Jun;195(6):482-495
pubmed: 30610355
Laryngoscope. 2006 Sep;116(9):1589-93
pubmed: 16954985
Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):159-169
pubmed: 28258895
Radiother Oncol. 2007 Oct;85(1):74-82
pubmed: 17673322
Eur J Cancer. 2000 Sep;36(14):1796-807
pubmed: 10974628
Radiat Oncol. 2009 Nov 12;4:52
pubmed: 19909531
Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):385-92
pubmed: 19553033
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):403-9
pubmed: 19467801
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e93-9
pubmed: 21592678
N Engl J Med. 2004 May 6;350(19):1937-44
pubmed: 15128893
Strahlenther Onkol. 2014 Feb;190(2):192-8
pubmed: 24362503
Acta Oncol. 2013 Oct;52(7):1535-42
pubmed: 24047339
Strahlenther Onkol. 2017 Nov;193(11):877-889
pubmed: 28616822
Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1356-65
pubmed: 20646872
Oral Oncol. 2015 Oct;51(10):888-900
pubmed: 26209066
Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1119-27
pubmed: 18472364
Radiother Oncol. 2007 Oct;85(1):64-73
pubmed: 17714815
Strahlenther Onkol. 2013 Mar;189(3):230-6
pubmed: 23319255
J Med Imaging Radiat Oncol. 2016 Dec;60(6):772-780
pubmed: 27122102
Eur J Surg Oncol. 2018 Apr;44(4):395-403
pubmed: 29395434
Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):925-33
pubmed: 25832685
Radiother Oncol. 2011 Dec;101(3):394-402
pubmed: 21664711
Oral Oncol. 2013 May;49(5):443-8
pubmed: 23318122

Auteurs

Marlen Haderlein (M)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Stefan Speer (S)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Oliver Ott (O)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Sebastian Lettmaier (S)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Markus Hecht (M)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Sabine Semrau (S)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Benjamin Frey (B)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Claudia Scherl (C)

Department of Otorhinolaryngology, Universitätsklinikum Mannheim, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
Department of Otorhinolaryngology, Universitätsklinikum, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Heinrich Iro (H)

Department of Otorhinolaryngology, Universitätsklinikum, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Marco Kesting (M)

Department of Oral and Maxillofacial Surgery, Universitätsklinikum, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Rainer Fietkau (R)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Classifications MeSH